Biological fermentation tank for pharmaceutical production
Ensure consistent high-yield biological culture results with reliable, scalable fermentation tanks, ideal for applications requiring optimal oxygenation and precise environmental control, such as when cultivating E. coli and producing life-saving vaccines.
Cultivates and Ferments Microbial Cultures
AUSTAR’s Biological Fermentation Tank offers a robust solution for scaling biopharmaceutical production from research to commercial operations. This tank is engineered for precision microbial cultivation and fermentation, accommodating volumes from 5 to 30 kiloliters, and is ideal for producing biological drugs, including insulin, HPV vaccines, and pneumococcal vaccines.
The fermentation process is controlled with state-of-the-art automation technologies, ensuring optimal conditions for high oxygen-consuming bacteria such as E. coli and Pichia pastoris cultures. Built to comply with GMP regulations and ASME-BPE standards, the tank guarantees safety and reliability in demanding pharmaceutical environments.
The equipment’s modular design facilitates seamless integration into existing production lines, with configurable options available for tailoring to specific needs. AUSTAR provides comprehensive engineering support, ensuring each tank meets precise operational requirements. Constructed from materials adhering to ASME-U, GB150, and PED standards, the tank offers durable performance with excellent corrosion resistance, maintaining integrity over extensive use.
Cleaning is efficient and contamination-free, supporting compliance with stringent industry regulations. This versatility makes the AUSTAR Biological Fermentation Tank an indispensable asset for companies aiming to enhance their biomanufacturing processes.
Benefits
- Supports scalable production, from R&D to commercial batches, enhancing operational flexibility.
- Ensures high-yield microbial cultures with precise environmental control, boosting production efficiency.
- Reduces compliance risks with GMP and ASME-BPE aligned design.
- Minimizes contamination through seamless CIP integration, maintaining product quality.
- Enhances equipment longevity and reliability with corrosion-resistant materials.
- Applications
- Vaccines,Microbial culture fermentation,Biopharmaceuticals,Recombinant protein drugs,Biological drugs
- End products
- E. coli cultures,Insulin,Hpv vaccine,Pneumococcal vaccine,Pichia pastoris cultures
- Steps before
- Laboratory research and development,Pilot scale production
- Steps after
- Commercial scale production,Quality measurement and analytics,Packging,Aseptic containment
- Input ingredients
- microbial culture,E. coli,Pichia pastoris
- Output ingredients
- recombinant protein drugs,insulin,vaccines,HPV vaccine,pneumococcal vaccine
- Market info
- Austar is known for specializing in the design and manufacture of engineered-to-order industrial equipment, particularly in the pharmaceutical and biotechnology sectors, offering solutions that focus on quality, innovation, and meeting specific customer requirements.
- Volume Range
- 5–30 kiloliters
- Compliance
- GMP regulations,ASME-BPE,ASME-U,GB150,PED
- Suitable for
- High oxygen consuming bacteria like E. coli and Pichia pastoris
- Application Scale
- Laboratory R,D to pilot scale to commercial scale
- Biological Drug Capability
- Recombinant protein drugs (e.g.,insulin),vaccines (HPV,pneumococcal)
- Customization
- Customized engineering solutions available
- Batch vs. continuous operation
- Batch
- CIP/SIP
- CIP 121°C / SIP 135°C
- Automation level
- PLC / SCADA
- Cleaning method
- CIP
- Changeover time
- Quick changeover
- Microorganism cultivation
- E. coli / Pichia pastoris
- Biological drugs
- Recombinant protein / Vaccines
- Tank Volume
- 5–30 kiloliters
- Modular design
- Yes
- Volume range
- 5–30 kiloliters
- Pressure vessel standards
- ASME-U,GB150,PED
- Production scale adaptability
- Laboratory,Pilot,Commercial
- User-friendly design
- Available